Internal Medicine, Infectious Disease · Kingsport, TN
NPI
1346773793
Since 2017
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4 Sheridan Sq Ste 200
Kingsport, TN, 37660
Phone (423) 246-7931
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
613 services
Medicare patients, 2024
203
Average age 72
Drug cost, 2024
$713K
617 prescriptions
Company payments, 2025
$97.13
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mathew C Finniss was code 99232 (hospital e&m - subsequent), 303 times for 130 patients. In total Mathew C Finniss billed 613 services in 17 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 303 | 130 | $57.31 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 125 | 59 | $87.06 | $11K |
| 99223 Hospital E&M - Initial | Facility | 73 | 70 | $125.30 | $9,147 |
| 99221 Hospital E&M - Initial | Facility | 57 | 57 | $60.01 | $3,421 |
| 99214 Office E&M - Established | Office | 19 | 12 | $83.82 | $1,593 |
By year: 2022 $29K for 404 services; 2023 $42K for 567 services; 2024 $44K for 613 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mathew C Finniss prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 105 prescriptions and refills. In total Mathew C Finniss wrote 617 Medicare prescriptions that cost $713K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 105 | 105 | 12 | $404K |
| Ceftriaxone Ceftriaxone Sodium | 57 | 57 | 17 | $12K |
| Vancomycin Hcl Generic | 34 | 34 | Under 11 | $6,062 |
| Cefepime Hcl Generic | 34 | 34 | Under 11 | $7,421 |
| Daptomycin Generic | 32 | 32 | Under 11 | $23K |
| Amikacin Sulfate Generic | 31 | 31 | Under 11 | $3,693 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 30 | 30 | Under 11 | $15K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 26 | 26 | Under 11 | $6,095 |
| Descovy Emtricitabine/Tenofov Alafenam | 17 | 17 | Under 11 | $36K |
| Cephalexin Generic | 16 | 16 | Under 11 | $351 |
| Prezcobix Darunavir/Cobicistat | 16 | 16 | Under 11 | $37K |
| Ertapenem Ertapenem Sodium | 15 | 15 | Under 11 | $7,760 |
| Minocycline Hcl Generic | 15 | 15 | Under 11 | $159 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 13 | 13 | Under 11 | $47K |
| Rosuvastatin Calcium Generic | 12 | 12 | Under 11 | $132 |
Brand drugs: 192 claims; generic drugs: 425 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mathew C Finniss $97.13 ($97.13 in general payments such as food, travel and fees) from 1 company. The largest payer was Shionogi Inc with $97.13.
| Company | Payments | Amount |
|---|---|---|
| Shionogi Inc 4507.T | 1 | $97.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.